Literature DB >> 11097213

Balancing thymocyte adhesion and motility: a functional linkage between beta1 integrins and the motility receptor RHAMM.

S L Gares1, L M Pilarski.   

Abstract

Thymocyte differentiation involves several processes that occur in different anatomic sites within the thymus. Therefore, thymocytes must have the ability to respond to signals received from stromal cells and adopt either adhesive or motile behavior. We will discuss our data indicating human thymocytes use alpha4beta1 integrin, alpha5beta1 integrin and RHAMM to mediate these activities. Immature multinegative (MN; CD3-4-8-19-) thymocytes use alpha4beta1 and alpha5beta1 integrins to mediate weak and strong adhesion. This subset also uses alpha4beta1 integrin to mediate motility. As thymocytes differentiate, they begin to express and use RHAMM to mediate motility in conjunction with alpha4beta1 and alpha5beta1 integrins. Motile thymocytes use beta1 integrins to maintain weakly adhesive contacts with substrate to provide traction for locomoting cells, thus weak adhesion is a requirement of motile behavior. Hyaluronan (HA) is also required by thymocytes to mediate motility. HA binding to cell surface RHAMM redistributes intracellular RHAMM to the cell surface where it functions to mediate motility. We propose that the decision to maintain adhesive or motile behavior is based on the balance between low and high avidity binding conformations of beta1 integrins on thymocytes and that RHAMM:HA interactions decrease high avidity binding conformations of integrins pushing the balance toward motile behavior.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11097213      PMCID: PMC2276043          DOI: 10.1155/2000/94616

Source DB:  PubMed          Journal:  Dev Immunol        ISSN: 1026-7905


  6 in total

1.  Augmentation of integrin-mediated mechanotransduction by hyaluronic acid.

Authors:  Anant Chopra; Maria E Murray; Fitzroy J Byfield; Melissa G Mendez; Ran Halleluyan; David J Restle; Dikla Raz-Ben Aroush; Peter A Galie; Katarzyna Pogoda; Robert Bucki; Cezary Marcinkiewicz; Glenn D Prestwich; Thomas I Zarembinski; Christopher S Chen; Ellen Puré; J Yasha Kresh; Paul A Janmey
Journal:  Biomaterials       Date:  2013-10-10       Impact factor: 12.479

2.  Secretory products of breast cancer cells upregulate hyaluronan production in a human osteoblast cell line.

Authors:  Nandita Bose; Anna M Masellis
Journal:  Clin Exp Metastasis       Date:  2006-04-27       Impact factor: 5.150

3.  Role of receptor for hyaluronic acid-mediated motility (RHAMM) in low molecular weight hyaluronan (LMWHA)-mediated fibrosarcoma cell adhesion.

Authors:  Katerina Kouvidi; Aikaterini Berdiaki; Dragana Nikitovic; Pavlos Katonis; Nikos Afratis; Vincent C Hascall; Nikos K Karamanos; George N Tzanakakis
Journal:  J Biol Chem       Date:  2011-09-13       Impact factor: 5.157

Review 4.  Hyaluronan: a simple polysaccharide with diverse biological functions.

Authors:  Kevin T Dicker; Lisa A Gurski; Swati Pradhan-Bhatt; Robert L Witt; Mary C Farach-Carson; Xinqiao Jia
Journal:  Acta Biomater       Date:  2013-12-18       Impact factor: 8.947

Review 5.  The 'sweet' and 'bitter' involvement of glycosaminoglycans in lung diseases: pharmacotherapeutic relevance.

Authors:  Eleni Papakonstantinou; George Karakiulakis
Journal:  Br J Pharmacol       Date:  2009-06-05       Impact factor: 8.739

6.  Hyaluronan anchored to activated CD44 on central nervous system vascular endothelial cells promotes lymphocyte extravasation in experimental autoimmune encephalomyelitis.

Authors:  Clayton W Winkler; Scott C Foster; Steven G Matsumoto; Marnie A Preston; Rubing Xing; Bruce F Bebo; Fatima Banine; Michelle A Berny-Lang; Asako Itakura; Owen J T McCarty; Larry S Sherman
Journal:  J Biol Chem       Date:  2012-08-03       Impact factor: 5.157

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.